World Journal of
Pharmaceutical and Life Sciences

A REVIEW ARTICLE ON NOVEL DRUGS USED IN PARKINSON’S DISEASE

*Professor Dr. Osman Ahmed and Madiha Jabeen

ABSTRACT

Parkinson’s disease is the most common Neuro-degenerative disorder. Several new medications are discovered, most of which are variations of previously existing products, such new dosage forms of already-approved products, or cost-saving generic formulations have been proposed. These new products contribute to the public health, safety of the people, greater access to medication, more consumer choice, and a competitive marketplace that enhances affordability and quality and care. However, these new approvals that we refer to as novel drugs are among the more truly innovative products that often help in advance clinical care to another level. This article includes study of existing drugs and novel drugs in the Parkinson’s disease treatment and also describes their medicinal chemistry i.e understanding its structure, synthesis, structural activity relationships, mechanism of action, therapeutic uses, adverse effects etc. These drugs are competent in various areas to satiate, make them suitable for its therapeutic use and for drug formulations and discoveries.

[Full Text Article]   [Download Certificate]